ClinicalTrials.gg
Not yet recruitingNCT07781761Updated Aug 25, 2026

Brain Stimulation With Combined Reading and Motor Training for Children With Dyslexia

An interventional study of Active transcranial direct current stimulation (tDCS) and Sham transcranial direct current stimulation (tDCS) in Developmental Dyslexia, sponsored by Shahid Beheshti University. Not yet recruiting at 1 site in Iran. Open to male participants aged 108 Months to 119 Months. Per ClinicalTrials.gov, last updated 2026-08-25.

Sponsored by Shahid Beheshti University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
108 Months to 119 Months
Sex
Male
01

Study summary

This study examines whether combining non-invasive brain stimulation (tDCS) with an integrated reading-and-motor training program improves reading and phonological processing in 9-year-old boys with developmental dyslexia.

Children with dyslexia often have difficulties in phonological awareness and fine motor skills. This study targets two brain areas at the same time: the left temporoparietal junction (important for reading and phonological processing) and the left primary motor cortex (important for hand movements and speech-related motor processes).

Participants will be randomly assigned to one of eight groups. Some groups will receive active brain stimulation, and some will receive sham (inactive) stimulation, while also participating in different types of training: phonological awareness training, fine motor training, combined phonological and fine motor training, or no training. The treatment includes 20 sessions, three times per week for about 7 weeks.

Reading and phonological skills will be measured before treatment, immediately after treatment, and again 3 months and 6 months later. The study will help determine whether a full treatment package-using brain stimulation together with combined reading and motor training-is more effective than single treatments or usual school education.

Read the detailed description

This is a randomized, double-blind, sham-controlled, 8-group component trial in 9-year-old boys with developmental dyslexia. The study tests a theory-driven prediction derived from multiple-deficit models of dyslexia: that simultaneously targeting reading-related and sensory-motor brain networks, while delivering an integrated phonological and fine motor intervention, produces greater and more durable reading improvement than single-component interventions.

The tDCS protocol uses 1 mA current for 20 minutes per session over 20 sessions (3 sessions/week). Electrode montages are yoked to the type of cognitive intervention: left temporoparietal (TPJ) for phonological training, left primary motor cortex (M1) for motor training, and dual-site TPJ+M1 for the combined intervention. A tDCS-only group (M1 montage) is included to isolate the effect of motor cortex stimulation.

Primary outcome: change in the composite score of Factor 1 of the Reading and Dyslexia Test (word reading, phoneme deletion, nonword reading, and word comprehension). Secondary outcomes: fine motor performance (BOT-2), rapid automatized naming, and text reading fluency.

Assessments occur at baseline, immediately after the intervention, and at 3- and 6-month follow-ups.

02

Conditions studied

  • Developmental Dyslexia

Browse trials for

Keywords

  • Developmental Dyslexia
  • tDCS
  • Phonological Awareness
  • Fine Motor Training
  • Reading
  • Children
  • Dual-site transcranial direct current stimulation
03

In context

Dyslexia

127 studies on the registry are indexed under Dyslexia; 27 are open to participants now.

This study's planned enrollment of 160 is above the median of 71 across 106 interventional studies indexed under Dyslexia.

Browse Dyslexia studies →

Lead sponsor

Shahid Beheshti University is the lead sponsor of 37 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
108 Months to 119 Months
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male children aged 9 years (9 years 0 months to 9 years 11 months) with developmental dyslexia diagnosed according to criteria by a clinical team.
  • Reading and Dyslexia Test (NAMA) T score ≤ 30 (at least 2 standard deviations below the mean).
  • Full Scale IQ ≥ 85 on the Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V).
  • Score below 88 on the Spence Children's Anxiety Scale (SCAS).
  • Fine motor deficits defined as standard score ≤ 40 on Bruininks-Oseretsky Test of Motor Proficiency, Second Edition (BOT-2) manual dexterity and upper-limb coordination subtests.
  • Normal or corrected-to-normal vision and hearing.
  • No history of seizure or epilepsy, no scalp skin disease, no cochlear implant, cardiac pacemaker, or metal implants in the skull.
  • Written from parents or legal guardian and verbal assent from the child.

Exclusion criteria

Exclusion Criteria:

  • Intellectual disability (Full Scale IQ \< 85).
  • Personal history of epilepsy or seizure disorder, or epilepsy in a first-degree relative.
  • Presence of cochlear implant, cardiac pacemaker, or metal implants in the skull.
  • Skin diseases or open lesions on the scalp at electrode sites.
  • Uncorrected visual or hearing impairments.
  • Other primary psychiatric or neurodevelopmental disorders requiring ongoing treatment (e.g., ADHD, autism spectrum disorder, severe anxiety disorder).
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
160 participants (estimated)

Study arms

  • Sham comparator
    Control (Sham + Usual School)

    Sham tDCS randomly selected montage + usual school education, no cognitive training

    Device: Sham transcranial direct current stimulation (tDCS) · Other: Usual school education

  • Sham comparator
    Sham-PA

    Sham tDCS TPJ + phonological awareness training

    Device: Sham transcranial direct current stimulation (tDCS) · Behavioral: Phonological awareness training

  • Sham comparator
    Sham-Motor

    Sham tDCS M1 + non-targeted fine motor training

    Device: Sham transcranial direct current stimulation (tDCS) · Behavioral: Non-targeted fine motor training

  • Sham comparator
    Sham-Comb

    Sham dual-channel TPJ+M1 + combined phonological and fine motor intervention

    Device: Sham transcranial direct current stimulation (tDCS) · Behavioral: Integrated phonological and fine motor intervention

  • Experimental
    Active-PA

    Active tDCS TPJ + phonological awareness training

    Device: Active transcranial direct current stimulation (tDCS) · Behavioral: Phonological awareness training

  • Experimental
    Active-Motor

    Active tDCS M1 + non-targeted fine motor training

    Device: Active transcranial direct current stimulation (tDCS) · Behavioral: Non-targeted fine motor training

  • Experimental
    Active-Comb

    Active dual-site TPJ+M1 + combined phonological and fine motor intervention

    Device: Active transcranial direct current stimulation (tDCS) · Behavioral: Integrated phonological and fine motor intervention

  • Experimental
    Active-Only

    Active tDCS M1 alone, no cognitive intervention

    Device: Active transcranial direct current stimulation (tDCS)

Interventions

  • DeviceActive transcranial direct current stimulation (tDCS)

    Active tDCS will be delivered at 1 milliampere for 20 minutes per session, 20 sessions over about 7 weeks. The montage varies by arm: left temporoparietal (TPJ) montage, left primary motor cortex (M1) montage, or dual-site TPJ+M1 montage.

    Also known as: tDCS

  • DeviceSham transcranial direct current stimulation (tDCS)

    Sham tDCS will use the same electrode positions as the active groups, but the current will be applied for only 30 seconds and then gradually ramped down.

    Also known as: Sham tDCS

  • BehavioralPhonological awareness training

    20 sessions of 60 minutes each, three times per week for about 7 weeks. Covers syllable segmentation, rhyme, phoneme blending and segmentation, initial and final phoneme identification, phoneme manipulation, and grapheme-to-phoneme mapping.

    Also known as: PA training

  • BehavioralNon-targeted fine motor training

    20 sessions of 60 minutes each, three times per week for about 7 weeks. Includes activities without linguistic content, such as free play with dough, bead threading, pegboard tasks, and other manual dexterity exercises.

    Also known as: Fine motor training

  • BehavioralIntegrated phonological and fine motor intervention

    20 sessions of 60 minutes each, three times per week for about 7 weeks. Combines phonological awareness training with targeted fine motor activities linked to reading, such as forming letters with dough and stringing beads marked with phonemes.

    Also known as: Combined intervention

  • OtherUsual school education

    Participants receive the standard school curriculum without additional cognitive or motor training.

06

What researchers measure

Primary outcomes

  1. Composite score of Factor 1 of the Reading and Dyslexia Test (NAMA)

    Composite score of Factor 1 of the Reading and Dyslexia Test, which includes word reading, phoneme deletion, nonword reading, and word comprehension subtests.

    Time frame: Before intervention, immediately after the end of intervention, 3 months after intervention, and 6 months after intervention.

Secondary outcomes

  1. Fine motor performance (BOT-2 manual dexterity and upper-limb coordination)

    Fine motor performance as measured by the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition, manual dexterity and upper-limb coordination subtests. Raw scores of the common items will be used for longitudinal comparison.

    Time frame: Before intervention, immediately after the end of intervention, 3 months after intervention, and 6 months after intervention.

  2. Rapid automatized naming speed

    Rapid automatized naming speed, including naming of objects, colors, numbers, and letters. The total time in seconds to name each card is recorded.

    Time frame: Before intervention, immediately after the end of intervention, 3 months after intervention, and 6 months after intervention.

  3. Text reading fluency (correct words per minute)

    Text reading fluency defined as the number of correct words read per minute on a grade-level reading passage. Correct words per minute will be calculated as the total number of words minus errors, multiplied by 60, divided by the total reading time in seconds.

    Time frame: Before intervention, immediately after the end of intervention, 3 months after intervention, and 6 months after intervention.

07

Study locations

1 site
  • Consultation, Psychological, Research and Specialized Services Center of Isfahan Province General Department of Education
    Isfahan, Isfahan 8155113853, Iran
    • Mohammad Amin Javedanfar, MSc · Contactm_javedanfar@sbu.ac.ir · +98 31 3265 5530
    • Mohammad Amin Javedanfar, MSc · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared due to confidentiality and ethical considerations related to minor participants. Sharing of participant-level data was not included in the informed consent or the study ethics approval. Only aggregate, deidentified results will be reported.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07781761
Lead sponsor
Shahid Beheshti University
Responsible party
Mohammad Amin Javedanfar (Principal Investigator, Shahid Beheshti University) — Principal investigator
First posted
Aug 24, 2026
Start date
Aug 23, 2026 (estimated)
Primary completion
Jul 6, 2027 (estimated)
Completion
Aug 1, 2027 (estimated)
Last update
Aug 25, 2026

Study contacts

Mohammad Amin Javedanfar, MSc
Contact
m_javedanfar@sbu.ac.ir
+98 21 2990 2761
Shahriar Gharibzadeh, Ph.D.
study chair · Institute for Cognitive and Brain Sciences, Shahid Beheshti University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion